Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induction therapy.

Mohamed A Bakr1

  • 1Urology and Nephrology Center, Mansoura, Egypt. adelbakr2001@yahoo.com

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|July 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal Transplantation in Mansoura, Egypt.

Transplantation·2020
Same author

Outcome of sirolimus-based immunosuppression, fifteen years post-live-donor kidney transplantation: Single-center experience.

Clinical transplantation·2018
Same author

Effect of Dexmedetomidine Added to Modified Pectoral Block on Postoperative Pain and Stress Response in Patient Undergoing Modified Radical Mastectomy.

Pain physician·2018
Same author

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Transplantation·2017
Same author

Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Transplantation·2017
Same author

Prevention of Transnational Transplant-Related Crimes-What More Can be Done?

Transplantation·2015
Same journal

Successful Anesthetic Management of Deceased Donor Liver Transplant in a Patient With Neonatal Sclerosing Cholangitis As a Result of DCDC2 (doublecortin domain-containing protein 2) Mutation: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Twenty-Year Follow-up After Combined Heart and Kidney Transplant: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Fibrin Hydrogel Containing Microvascular Fragments for Improving Subcutaneous Islet Transplants in Diabetic Rats.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Investigation of the Relationship Between Antibody-Mediated Rejection and Serum Interleukin 40 Levels in Heart Transplant Patients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Effect of Body Mass Index on Complications and Survival After Living Donor Liver Transplantation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Tacrolimus Levels 10 Years After Kidney Transplant and Long-Term Clinical Outcomes: A Propensity Score-Matched Analysis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
See all related articles

Organ transplant recipients benefit from induction therapy using immunosuppressive antibodies. These agents help manage rejection and reduce side effects, improving patient outcomes in transplantation.

Area of Science:

  • Immunology
  • Transplant Medicine
  • Pharmacology

Background:

  • Organ transplantation is a vital treatment for end-stage organ failure.
  • Selecting appropriate immunosuppressive regimens for maintenance and rejection treatment is complex.
  • Induction therapy, using high-dose conventional agents or antibodies, is a key strategy.

Purpose of the Study:

  • To review the role and evolution of antibody-based induction therapy in organ transplantation.
  • To highlight the benefits of antibody therapy in augmenting immunosuppression and managing specific patient populations.
  • To discuss the impact of induction therapy on short- and long-term transplant outcomes.

Main Methods:

  • Review of current literature on immunosuppressive agents and induction therapy protocols.

Related Experiment Videos

  • Analysis of the mechanisms and clinical applications of various antibody types (anti-thymocyte globulin, anti-CD3, anti-CD20, anti-CD25, anti-CD52).
  • Evaluation of the impact of induction therapy on patient outcomes, including rejection rates and adverse events.

    • Main Results:

    • Antibody induction therapy is integral to modern transplant medicine.
    • Therapeutic goals include enhanced immunosuppression, safe calcineurin inhibitor introduction, steroid withdrawal, and managing sensitized patients.
    • Evolution of antibody agents from anti-thymocyte globulin to targeted therapies like anti-CD20 and anti-CD52.

    Conclusions:

    • Induction therapy, particularly with antibodies, offers significant benefits for transplant recipients.
    • It is associated with improved short- and long-term outcomes, especially when managing risks of infection (e.g., cytomegalovirus) and malignancy (e.g., lymphomas).
    • Tailoring induction strategies is crucial for optimizing immunosuppression and minimizing adverse effects.